2019
CDC and Clinical Laboratory Partners: Analysis of Biosafety Gaps Revealed During the Ebola Outbreak
Cornish N, Campbell S, Weirich E. CDC and Clinical Laboratory Partners: Analysis of Biosafety Gaps Revealed During the Ebola Outbreak. American Journal Of Clinical Pathology 2019, 152: s139-s139. DOI: 10.1093/ajcp/aqz128.001.Peer-Reviewed Original ResearchClinical laboratory testingPatient specimensClinical laboratoriesPatient careInfectious materialHealth care providersPatient deathPatient visitsLaboratory testingMedical CenterCare providersTest utilizationDisease controlBiosafety practicesSpecimen collectionEbola outbreakPublic healthMedical decisionsImportance of biosafetyCareCompetency assessmentLaboratory testsEbola crisisRisk assessmentLaboratory biosafety
2017
Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing
Hauser RG, Campbell SM, Brandt CA, Wang S. Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing. Journal Of Clinical Microbiology 2017, 55: 1566-1575. PMID: 28298450, PMCID: PMC5405275, DOI: 10.1128/jcm.00119-17.Peer-Reviewed Original ResearchConceptsCerebrospinal fluidHerpes simplex virus (HSV) central nervous system (CNS) infectionPCR testingCentral nervous system infectionCSF white blood cellsHSV PCR testingNervous system infectionLarge health care systemWhite blood cellsCost-effectiveness studiesHealth care systemDecision analysis modelHSV encephalitisCNS infectionSystem infectionHSV infectionAbsence of markersImmunocompetent hostsNecessary diagnostic testsOrgan transplantsPatient careDiagnostic testsBlood cellsCare systemPCR test